- Home
- INKT vs DTIL Comparison
INKT vs DTIL Comparison
Compare INKT & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- DTIL
- Stock Information
- Founded
- INKT 2017
- DTIL 2006
- Country
- INKT United States
- DTIL United States
- Employees
- INKT N/A
- DTIL N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- DTIL Health Care
- Exchange
- INKT Nasdaq
- DTIL Nasdaq
- Market Cap
- INKT 36.7M
- DTIL 43.3M
- IPO Year
- INKT 2021
- DTIL 2019
- Fundamental
- Price
- INKT $8.43
- DTIL $5.09
- Analyst Decision
- INKT Strong Buy
- DTIL Strong Buy
- Analyst Count
- INKT 2
- DTIL 3
- Target Price
- INKT $19.50
- DTIL $37.67
- AVG Volume (30 Days)
- INKT 12.3K
- DTIL 124.0K
- Earning Date
- INKT 03-18-2025
- DTIL 03-26-2025
- Dividend Yield
- INKT N/A
- DTIL N/A
- EPS Growth
- INKT N/A
- DTIL N/A
- EPS
- INKT N/A
- DTIL 1.45
- Revenue
- INKT N/A
- DTIL $75,096,000.00
- Revenue This Year
- INKT N/A
- DTIL $51.35
- Revenue Next Year
- INKT N/A
- DTIL N/A
- P/E Ratio
- INKT N/A
- DTIL $3.47
- Revenue Growth
- INKT N/A
- DTIL 43.62
- 52 Week Low
- INKT $4.56
- DTIL $3.61
- 52 Week High
- INKT $19.00
- DTIL $15.97
- Technical
- Relative Strength Index (RSI)
- INKT 41.71
- DTIL 44.58
- Support Level
- INKT $7.54
- DTIL $4.90
- Resistance Level
- INKT $8.88
- DTIL $5.33
- Average True Range (ATR)
- INKT 0.86
- DTIL 0.32
- MACD
- INKT -0.25
- DTIL -0.05
- Stochastic Oscillator
- INKT 6.05
- DTIL 21.99
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.